From October 31, 2023 to December 31, 2023, the company has repurchased 1,985,118 shares, representing 0.47% for CNY 38.99 million. With this, the company has completed the repurchase of 1,985,118 shares, representing 0.47% for CNY 38.99 million under the buyback announced on October 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.85 CNY | +2.39% |
|
-1.38% | -21.31% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-21.31% | 73Cr | |
+54.99% | 81TCr | |
+44.25% | 65TCr | |
-6.10% | 35TCr | |
+21.38% | 34TCr | |
+11.13% | 30TCr | |
+18.45% | 25TCr | |
+2.09% | 23TCr | |
+13.03% | 22TCr | |
+8.96% | 17TCr |
- Stock Market
- Equities
- 301263 Stock
- News Guangdong Taienkang Pharmaceutical Co., Ltd.
- Tranche Update on Guangdong Taienkang Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on October 31, 2023.